# A Managerial Approach to Investigate Fall Risk in a Rehabilitation Hospital
## 3 Results
\begin{table}
\begin{tabular}{c c c c c c} \hline \hline  & & \multicolumn{2}{c}{**without**} & \multicolumn{2}{c}{**with**} \\
**Variables** & **Categories** & **Recurrences** & **Recurrences** & \(p\)**-Value** \\  & & **(n = 200)** & **(n = 38)** & \\ \hline Years, mean \(\pm\) St. dev. & - & 72.6 \(\pm\) 12.1 & 72.1 \(\pm\) 10.9 & 0.406 \\ \hline \multirow{4}{*}{Mobility, n [\%]} & Bedridden & 15 [7.5] & 4 [10.5] & \\  & Assisted with aids & 90 [45.0] & 25 [65.8] & \\  & Assisted without aids & 14 [7.0] & 2 [5.3] & \\  & Autonomous with aids & 53 [26.5] & 5 [13.1] & \\  & Autonomous without aids & 28 [14.0] & 2 [5.3] & \\ \hline \multirow{4}{*}{State of consciousness, n [\%]} & Psychomotor agitation & 6 [3.0] & 8 [21.0] & \\  & Confusion & 11 [5.5] & 5 [13.2] & \textless{}0.001 *** \\  & Vigilant & 183 [91.5] & 25 [65.8] & \\ \hline \multirow{4}{*}{Drug acting on vital signs} & Antiarrhythmics, n [\%] & Yes & 51 [25.5] & 5 [13.2] & \\  & n [\%] & No & 149 [74.5] & 33 [86.8] & 0.100 \\ \cline{2-6}  & Diuretics, n [\%] & Yes & 105 [52.5] & 18 [47.4] & \\  & Diuretics, n [\%] & No & 95 [47.5] & 20 [52.6] & 0.562 \\ \cline{2-6}  & Hypotensive, n [\%] & Yes & 136 [68.0] & 30 [78.9] & \\  & Hypotensive, n [\%] & No & 64 [32.0] & 8 [21.1] & 0.178 \\ \cline{2-6}  & Hypoglycemics, n [\%] & Yes & 10 [5.0] & 5 [13.2] & \\  & n [\%] & No & 190 [95.0] & 33 [86.8] & 0.058 \\ \cline{2-6}  & \multirow{2}{*}{Laxatives, n [\%]} & Yes & 14 [7.0] & 3 [7.9] & \\  & No & 186 [93.0] & 35 [92.1] & 0.844 \\ \hline \multirow{4}{*}{Psychoactive drugs} & Hypotics, n [\%] & Yes & 17 [8.5] & 7 [18.4] & \\  & No & 183 [91.5] & 31 [81.6] & 0.063 \\ \cline{2-6}  & Opioid, n [\%] & Yes & 2 [1.0] & 0 [0.0] & \\  & No & 198 [99.0] & 38 [100.0] & 0.536 \\ \cline{2-6}  & Sedatives, n [\%] & Yes & 38 [19.0] & 13 [34.2] & \\  & No & 162 [81.0] & 25 [65.8] & 0.036 \\ \hline \multirow{2}{*}{Visual impairment, n [\%]} & Yes & 20 [10.0] & 2 [5.3] & \\  & No & 180 [90.0] & 36 [94.7] & 0.428 \\ \hline \multirow{2}{*}{Antidepressants, n [\%]} & Yes & 32 [16.0] & 13 [34.2] & \\  & No & 168 [84.0] & 25 [65.8] & 0.009 *** \\ \hline \multirow{2}{*}{Antiepileptics, n [\%]} & Yes & 28 [14.0] & 5 [13.2] & \\  & No & 172 [86.0] & 33 [86.8] & 0.890 \\ \hline \multirow{2}{*}{No drug therapy, n [\%]} & Yes & 6 [3.0] & 1 [2.6] & \\  & No & 194 [97.0] & 37 [97.4] & 0.902 \\ \hline \multirow{2}{*}{Antiparkinsonians, n [\%]} & Yes & 3 [1.5] & 0 [0.0] & \\  & No & 197 [98.5] & 38 [100.0] & 0.447 \\ \hline \multirow{2}{*}{Systemic antihistamines, n [\%]} & Yes & 1 [0.5] & 0 [0.0] & \\  & No & 199 [99.5] & 38 [100.0] & 0.662 \\ \hline \multirow{2}{*}{Morse, mean \(\pm\) St. dev.} & - & 32.5 \(\pm\) 17.8 & 53.3 \(\pm\) 22.1 & \textless{}0.001 *** \\ \hline \multirow{4}{*}{Stratify, n [\%]} & 0 & 8 [15.4] & 0 [0.0] & \\  & 1 & 26 [50.0] & 5 [23.8] & \\ \cline{1-1}  & 2 & 16 [30.8] & 10 [47.6] & 0.004 ** \\ \cline{1-1}  & 3 & 2 [3.8] & 5 [23.8] & \\ \cline{1-1}  & 4 & 0 [0.0] & 1 [4.8] & \\ \hline \multirow{2}{*}{Risk, n [\%]} & Yes, preventive & 51 [25.5] & 15 [39.5] & \\ \cline{1-1}  & personalized measures & & & \\ \cline{1-1}  & Yes, preventive & 149 [74.5] & 23 [60.5] & \\ \cline{1-1}  & standard measures & & & \\ \hline \hline \end{tabular}
\end{table} 
Table 3: Comparison among anamnestic and clinical parameters between patients who fell once and those who fell twice or more. Statistical significance for \(p\leq\) 0.01. **: 0.01 \(<\)\(p\) 0.001. ***: \(p\)\(<\) 0.001.